Lumiracoxib - ≥98%, high purity , Cyclooxygenase-2 inhibitor, CAS No.220991-20-8, Cyclooxygenase-2 inhibitor

Item Number

L129349

• Synonyms: Lumiracoxib | 220991-20-8 | Prexige | COX-189 | Lumaricoxib | COX 189 | COX189 | Prexige;COX 189 | 2-(2-((2-chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid | 2-((2-Chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid | CHEMBL404108 | DTXSID9049035 | CHEBI:73044 | {2-[(2
• Specifications & Purity: Moligand™, ≥98%
• Biochemical and Physiological Mechanisms: Lumaricoxib is a Cox-2 selective inhibitor NSAID member of the arylalkanoic acid family of NSAIDs. Lumaricoxib binds to a separate site than that of other Cox-2 inhibitors.Potent and selective COX-2 inhibitor (K i = 60 nM). Orally active. Anti-inflammator
• Storage Temp: Store at -20°C
• Shipped In: Ice chest + Ice pads
• Grade: Moligand™
• Action Type: INHIBITOR
• Mechanism of action: Cyclooxygenase-2 inhibitor
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Lumiracoxib is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1.
A Cox-2 selective inhibitor and NSAID.